Alectinib Pharmacokinetic in Patients With NSCLC

Clinical trial NCT05713006 · RECRUITING

Trial details

NCT number: NCT05713006
Sponsor: Instituto Nacional de Cancerologia de Mexico
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IIIB ALK Gene Mutation

Start date: 2022-05-01
Primary completion: 2026-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.